Forget Global Warming. Worry About Global Click Farms.
Some farms have 17,000 phones ready to 'auto-click' on any click on anything you want. Fake views, fake reviews - you want it, we...
A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.
With Toronto Grabbing Some of the Best Israeli Tech Listings Away From NASDAQ, We Saw This Coming.
From Reuters.
TEL AVIV (Reuters) - Israel and the...
MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)
AIRPORT CITY, Israel, June 27, 2019 /PRNewswire/ -- My Size, Inc. (the "Company" or "My Size") (MYSZ) (MYSZ), the developer and creator of smartphone measurement solutions, today announced...
Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.
- Rule 506(c) Offering Solely to Accredited Investors -
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Redefy Corporation* (a/k/a Mister Goody, Inc.) (OTC Pink: MSGO),...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to Prilosec ® ....
Diabasens® to Launch in Europe. Innovus (INNV).
"The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by local distributors...
Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.
The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial results and...
Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)
(Originally published 4/25/2018)
“I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...
Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current therapeutic conventions....
Latest article
Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Adding to Watch List....
In 2020, we Released the "Biotech 5 Pack" Which Later Grew to a 6 Pack, with a Byline "6 Stocks We Expect to Double"...
REPORT OpenWorld: The Contrarian’sCase for OPNW
Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some.
LIVE QUOTE
RECENT NEWS
VerifyMe Reports Fourth Quarter...
$269 Million in Cash and a $178 Million Market Cap. What are the Odds?...
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but don't go crazy, we're down to $269...
